ADAR1 Capital Management, LLC
Top Portfolio Positions
283 positions ·
$1,609,386,349 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ABVX |
Abivax S.A.
Healthcare
|
1,438,019 | $160,123,415 | 9.95% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
994,119 | $104,780,142 | 6.51% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
3,285,906 | $91,019,596 | 5.66% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
2,679,010 | $66,546,608 | 4.13% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
1,114,699 | $58,766,931 | 3.65% | |
| SPY |
Spdr S&P 500 ETF Trust
|
75,940 | $49,386,819 | 3.07% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
632,556 | $41,691,765 | 2.59% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
1,139,331 | $41,380,501 | 2.57% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
1,871,455 | $35,931,936 | 2.23% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
1,446,375 | $34,467,116 | 2.14% |
Portfolio Trend
Holdings in SYRE
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,065,012 | 338,323 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,115,510 | 34,051 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $570,694 | 34,051 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $509,743 | 34,051 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $242,557 | 15,033 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $369,389 | 12,560 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $827,081 | 35,180 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,877,535 | 49,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $138,588 | 6,440 | Shares | Sole | 2024-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||